The Cell Cycle – Theory and Application to Cancer

Oncology Research and Treatment

Volumn 19, Issue 6, 1996, Pages 464-472

  Parwaresch, R ^a   Rudolph, P ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Cell cycle; Checkpoint; Cyclin; Cyclin dependent kinase; Cyclin kinase inhibitors; p53; Rb

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER; CELL CYCLE; REVIEW;

EID: 0030513456     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218858     Document Type: Article

References (82)

1. Baker FL, Sanger IJ, Rodgers RW, Jabboury K, Mangini OR: Cell proliferation kinetics of normal and tumour tissue in vitro: Quiescent reproductive cells and the cycling reproductive fraction, Cell Prolif 1995;28:1-15.
2. Parwaresch MR, Wackcr HH: Origin and kinetics of resident tissue macrophages, Parabiosis studies with radiolabelled leucocytes, Cell Tissue Kinet 1984:17: 25-39.
3. Parwaresch MR, Walle AJ, Arndt D: 'Hie peripheral kinetics of human radio-labeled eosinophils, Virchows Arch B Cell Pathol 1976:21:57-66.
4. Parwaresch MR, Walle AJ, Voigt J: An unusual labeling index pattern of neutrophilic granulocytes after a 3H-thymidinc flash labeling injection, Virchows Arch B Cell Pathol 1980:33:177-185.
5. Hall PA, Coates PJ, Ansari B, Hopwood D: Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis, J Cell Sci 1994;107:3569-3577.
6. Hall PA, Lane DP: Genetics of growth arrest and cell death: Key determinants of tissue homeostasis, Fur J Cancer 1994;30A:2101-2112.
7. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
8. Lane DP: Cancer: p53. guardian of the genome, Nature 1992358:15-16.
9. Morgenbesser SD, Williams BO, Jacks T, DcPinho RA: p53-dependcnt apoptosis produced by Rb-defi-ciency in the developing mouse lens, Nature 1994:371:72-74.
10. White F,: Tumour biology, p53. guardian of Rb, Nature 1994:371:21-22.
11. McClintock B: Chromosome organization and genic expression, Cold Spring Harbor Symp Quant Biol 1951:16:13-47.
12. Norbury C, Nurse P: Animal cell cycles and their control, Annu Rev Biochem 1992:61:441-470.
13. Norbury C, Blow J, Nurse P: Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates, EMBOJ 1991:10:3321-3329.
14. Hadwiger JA, Wittenberg C, Richardson HE, de Barros Lopes M, Reed SI: A family of cvclin homologs that control the Gl phase in yeast, Proc Natl Acad Sci USA 1989:86:6255-6259.
15. Murray A: Cyclin ubiquitination: The destructive end of mitosis, Cell 1995:81:149-152.
16. Desai D, Wesseling HC, Fisher RP, Morgan DO: Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol Cell Biol 1995:15:345-350.
17. Gualberto A, Ilixon ML, Finco IS, Perkins ND, Nabel GJ, Baldwin ASI: A proliferative p53-respon-sivc element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeal, Mol Cell Biol 1995:15: 3450-3459.
18. Nurse P: Universal control mechanism regulating the onset of M-phase, Nature 1990:344:503-508.
19. Solomon MJ, Lee T, Kirschner MW: Role of phosphorylation in p34cdc2 activation: Identification of an activating kinase, Mol Biol Cell 1992:3:13-27.
20. Nigg EA: Targets of cyclin-dependent protein kinases, CurrOpin Cell Biol 1993:5:187-193.
21. Sherr CJ: Mammalian Gl cyclins, Cell 1993:73: 1059-1065.
22. Sherr CJ: Gl phase progression: Cycling on cue, Cell 1994;79:551-555.
23. Knoblich JA, Sauer K, Jones L, Richardson H, Saint R, Lehner CF: Cyclin E controls S phase progression and its down-regulaiion during Drosophila embryogenesis is required lor the arrest of cell pro lileration, Cell 1994:77:107-120.
24. Girard F, Strausfeld IJ, Fernandez A, Lamb NJC: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts, Cell 1991;67: 1169-1179.
25. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins, Cell 1993: 73:499-511.
26. Shao Z, Robbins PD: Differential regulation of E2F and Spl -mediated transcription by G1 cyclins, Oncogene 1995:10:221-228.
27. Okamoto K, Beach D: Cyclin G is a transcriptional target of the p53 tumor suppressor protein, EM BO J 1994;13:4816-4822.
28. Bai C, Richman R, Elledge SJ: Human cyclin E EMBOJ 1994:13:6087-6098.
29. Kobayashi S, Ishiguro K, Omori A, Takamatsu M, Arioka M, Imahori K, IJchida T: A cdc2-related kinase PSSAI, RE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule, FEBS Lett 1993:335:171-175.
30. Feaver WJ, Svejstrup JQ, Henry NL, Kornberg RD: Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK, Cell 1994: 79:1103-1109.
31. Svejstrup JQ, Wang Z, Feaver WJ, Wu X, Bushnell DA, Donahue IT, Friedberg EC, Kornberg RD: Different forms of TFIIH for transcription and DNA repair: Holo-TFIIH and a nucleotide excision repairosome, Cell 1995:80:21-28.
32. Hunter R, Pines J: Cyclins and cancer II: Cyclin D and CDK inhibitors come of age, Cell 1994:79: 573-582.
33. Harper JW, Elledgc SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell Crowley L, Swindell E, ct al,: Inhibition of cvclin-dcpendent kinases by p2l, Mol Biol Cell 1995:6: 387-400.
34. cl Dciry WS, Harper JW, O'Connor PM, Velcu-lescu VE, Canman CE, Jackman J, Pictenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis, Cancer Res 1994:54:1169-1174.
35. Chen J, Jackson PK, Kirschner MW, Dutta A: Separate domains of p2l involved in the inhibition of Cdk kinase and PCNA, Nature 1995:374:386-389.
36. McCormick D, Hall PA: The complexities of proliferatingcell nuclear antigen, Histopathology 1992: 21:591-594.
37. Polyak K, Lee MH, Erdjument Bromage H, Koff A, Roberts JM, Tempst P, Massaguc J: Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimilogenic signals, Cell 1994:78:59-66.
38. Lee MH, Reynisdottir I, Massaguc J: Cloning of p57KIP2. a cyclin-dcpendent kinase inhibitor with unique domain structure and tissue distribution, Genes Dev 1995:9:639-649.
39. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57KIP2. a structurally distrinct member of the p21C1P1 Cdk inhibitor family, is a candidate tumor suppressor gene, Genes Dev 1995:9:650-662.
40. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y: Growth suppression by pis, a pl6INK4/, MTSI- and p 141NK4B/M rS2-related CDK6 inhibitor, correlates with wild-type pRb function, Genes Dev 1994:8:2939-2952.
41. Hirai H, Roussel ME Kato JY, Ashmun RA, Sherr CJ: Novel INK4 proteins, p!9 and pl8. are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 1995:15:2672-2681.
42. Kamb A, Gruis NA, Weaver Fcldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types, Science 1994:264:436-440.
43. Hartwell LH, Weinert TA: Checkpoints: Controls that ensure the order of cell cycle events, Science 1989:246:629-634.
44. Ewen ME: The cell cycle and the retinoblastoma protein family, Cancer Metastasis Rev 1994:13: 45-66.
45. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D: The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in lumorigenesis, Br J Cancer 1994;69:409-416.
46. Perry ME, Levine AJ: Tumor-suppressor p53 and the cell cycle, Curr Opin Genet Dev 1993;3:50-54.
47. Zhan Q, Bae I, Kastan MB, Fornace AJJ: The p53-dependent gamma-ray response of GADD45. Cancer Res 1994:54:2755-2760.
48. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA: p53 involvement in control of G2 exit of the cell cycle: Role in DNA damage-induced apoptosis, Oncogene 1995:10: 2263-2270.
49. Kellner U, Heidebrecht HJ, Rudolph P, Biersack H, Buck F, Dakowski T, Wacker MH, Domanowski M, Seidel A, Westergaard O, Parwaresch R: Detection of topoisomerase II alpha in cell lines and tissues -Characterization of five novel monoclonal antibodies, J Histochem Cytochem 1996 (in press).
50. Downes CS, Clarke DJ, Mullinger AM, Gimenez Abian JF, Creighton AM, Johnson RT: A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells, Nature 1994:372:467-470.
51. Li X, Nicklas RB: Mitotic forces control a ccll-cycle checkpoint, Nature 1995:373:630-632.
52. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint, Science 1995:267:1353-1356.
53. Andreasscn PR, Margolis RL: Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells, J Cell Biol 1994:127:789-802.
54. Majno G, Joris I: Apoptosis, oncosis, and necrosis, An overview of cell death, Am J Pathol 1995:146: 3-15.
55. Vaux DL, Haecker G, Strasser A: An evolutionary perspective of apoptosis, Cell 1994:76:777-779.
56. Meikrantz W, Schlegel R: Apoptosis and the cell cycle, J Cell Biochem 1995:58:160-174.
57. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labcllc M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature 1995; 376:37-43.
58. Reid BJ, Sanchez CA, Blount PL, Levine DS: Barrett's esophagus: Cell cycle abnormalities in advancing stages of neoplastic progression, Gastroenterology 1993:105:119-129.
59. Quinn CM, Wright NA: The clinical assessment of proliferation and growth in human tumours: Evaluation of methods and applications as prognostic variables, J Pathol 1990:160:93-102.
60. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984:133: 1710-1715.
61. Gerdes J, Li L, Schluter C, Cuchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H-D: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991:138:867-873.
62. Schlüter C, Duchrow M, Wohlenberg C, Becker MUG, Key G, Flad H-D, Gerdes J: The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins, J Cell Biol 1993:123: 513-522.
63. Lopez F, Belloc F, Lacombe F, Dumain P, Feiffers J, Bernard P, Boisseau MR: The labeling of proliferating cells by Ki67 and Mib-1 antibodies depends on the binding of a nuclear protein to the DNA, Exp Cell Res 1994:210:145-153.
64. Schwarting R: Little missed markers and Ki-67. Lab Invest 1993:68:597-599.
65. Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad II-D, Gerdes J: New Ki-67-equiva-lent murine monoclonal antibodies (MIB 1-3) generated against bacteriallv expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope, Lab Invest 1993:68:629-636.
66. Kreipe H, Wacker HH, Heidebrecht HJ, Haas K, Hauberg M, Tiemann M, Parwaresch R: Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen, Am J Pathol 1993:142:1689-1694.
67. Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E: Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions, Am J Pathol 1995:147:1615-1625.
68. Rudolph P, Lappe T, Kreipe H, Parwaresch MR, Schmidt D: Assessment of the growth fraction in prostate cancer by means of the nuclear proliferation associated formalin-resistant antigen Ki-S5. Verh Dtsch C, es Pathol 1993;77:98-102.
69. Rudolph P, Lappe T, Hero B, Berthold F, Parwaresch R, Harms D, Schmidt D: Prognostic significance of the proliferative activity in neuroblastoma, AmJ Pathol 1996 (in press)
70. Rudolph P, Kellner U, Chassevent A, Collin F, Bonichon F, Parwaresch R, Coindre JM: Prognostic factors for soft tissue sarcoma in adult patients: Relevance of proliferation markers Ki-SU and Ki-Sl, AmJ Pathol 1996 (submitted).
71. Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA), Structural conservation and the detection of a nucleolar form, J Cell Sci 1990;96:121-129.
72. Gillett CE, Barnes DM, Camplejohn RS: Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma, J Clin Pathol 1993:46:1126-1128.
73. Hall PA, Levison DA: Review: Assessment of cell proliferation in histological material, J Clin Pathol 1999:43:184-192.
74. Heck MMS, Earnshaw WC: Topoisomerase II: A specific marker for cell proliferation, J Cell Biol 1986:103:2569-2581.
75. Tsutsui K, Okada S, Watanabe M, Shohmori T, Seki S, Inoue Y: Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development, J Biol Chem 1993:268:19076-19083.
76. Rudolph P, Heidebrecht H-J, Kellner U, Seidel A, Parwaresch MR: Proliferation marker Ki-Sl binds to a formalin-resistant epitope of topoisomerase II, Int J Surg Pathol 1995:2:388 (Abstract).
77. Camplejohn RS, Brock A, Barnes DM, Gillett C, Raikundalia B, Kreipe H, Parwaresch MR: Ki-Sl, a novel proliferative marker: Flow cytometric assessment of staining in human breast carcinoma cells, Br J Cancer 1993:67:657-662.
78. Sampson SA, Kreipe H, Gillett CE, Smith P, Chaudary MA, Khan A, Wicks K, Parwaresch R, Barnes DM, KiSI a novel monoclonal antibody which recognizes proliferating cells: Evaluation of its relationship to prognosis in mammary carcinoma, J Pathol 1992:168:179-185.
79. Kreipe H, Heidebrecht HJ, Hansen S, Rohlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R: A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-Sl, Am J Pathol 1993;142:3-9.
80. Shi S-R, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections, J Histochem Cytochem 1991;39:741-748.
81. Yu CC-W, Filipe MI: Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications, Histochem J 1993 25:843-853.
82. Kreipe H, Aim P, Olsson H, Hauberg M, Fischer L, Parwaresch R: Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-Sl, Am J Pathol 1993:142:651-657.